ferric gluconate
(OZNJXEMJJHFYON-MLBGHZOFSA-J)
Structure
- SMILES
- OC[C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O.OC[C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O.OC[C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O.OC[C@H]([C@H]([C@@H]([C@H](C(=O)[O-])O)O)O)O.[Na+].[Fe+3]
- Molecular Formula:
- C24H44FeNaO28
- Molecular Weight:
- 859.424
- Log P:
- -19.3137
- Hydrogen Bond Acceptor:
- 28
- Hydrogen Bond Donor:
- 20
- TPSA:
- 565.12
- CAS Number(s):
- 34089-81-1; 77257-36-4
Synonym(s)
1.
ferric gluconate
2.
Ferrlecit
3.
Ferrlecit 100
4.
ferric gluconate anhydrous
5.
ferric gluconate trihydrate
6.
ferric gluconate, sodium salt
7.
sodium ferrigluconate
8.
sodium iron(III)gluconate
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Nausea | FAERS: 80 | US FAERS | |
| 2 | Hypotension | FAERS: 65 | US FAERS | |
| 3 | Vomiting | FAERS: 62 | US FAERS | |
| 4 | Abdominal Pain | FAERS: 42 | US FAERS | |
| 5 | Back Pain | FAERS: 36 | US FAERS | |
| 6 | Dizziness | FAERS: 35 | US FAERS | |
| 7 | Urticaria | FAERS: 34 | US FAERS | |
| 8 | Chest Pain | FAERS: 33 | US FAERS | |
| 9 | Asthenia | FAERS: 27 | US FAERS | |
| 10 | Arthralgia | FAERS: 25 | US FAERS | |
| 11 | Chest discomfort | FAERS: 25 | US FAERS | |
| 12 | Burning sensation | FAERS: 21 | US FAERS | |
| 13 | Erythema | FAERS: 20 | US FAERS | |
| 14 | Pruritus | FAERS: 20 | US FAERS | |
| 15 | Flushing | FAERS: 18 | US FAERS | |
| 16 | Headache | FAERS: 16 | US FAERS | |
| 17 | Peripheral swelling | FAERS: 15 | US FAERS | |
| 18 | Swelling | FAERS: 15 | US FAERS | |
| 19 | Hypersensitivity | FAERS: 14 | US FAERS | |
| 20 | Syncope | FAERS: 14 | US FAERS | |
| 21 | Malaise | FAERS: 13 | US FAERS | |
| 22 | Chills | FAERS: 12 | US FAERS | |
| 23 | Joint swelling | FAERS: 12 | US FAERS | |
| 24 | Urinary Incontinence | FAERS: 12 | US FAERS | |
| 25 | Pain | FAERS: 11 | US FAERS | |
| 26 | Bradycardia | FAERS: 10 | US FAERS | |
| 27 | Anaphylactoid Reaction | FAERS: 9 | US FAERS | |
| 28 | Fatigue | FAERS: 9 | US FAERS | |
| 29 | Feeling abnormal | FAERS: 9 | US FAERS | |
| 30 | Injection site pain | FAERS: 9 | US FAERS | |
| 31 | Product quality issue | FAERS: 9 | US FAERS | |
| 32 | Tachycardia | FAERS: 9 | US FAERS | |
| 33 | Dysphonia | FAERS: 8 | US FAERS | |
| 34 | Extravasation | FAERS: 8 | US FAERS | |
| 35 | Lip swelling | FAERS: 8 | US FAERS | |
| 36 | Respiratory distress | FAERS: 8 | US FAERS | |
| 37 | Cold sweat | FAERS: 7 | US FAERS | |
| 38 | Pallor | FAERS: 7 | US FAERS | |
| 39 | Throat irritation | FAERS: 7 | US FAERS | |
| 40 | Unresponsive to stimuli | FAERS: 7 | US FAERS | |
| 41 | Abdominal discomfort | FAERS: 6 | US FAERS | |
| 42 | Cyanosis | FAERS: 6 | US FAERS | |
| 43 | Infusion Site Extravasation | FAERS: 6 | US FAERS | |
| 44 | Lethargy | FAERS: 6 | US FAERS | |
| 45 | Musculoskeletal stiffness | FAERS: 6 | US FAERS | |
| 46 | Cardiac Arrest | FAERS: 5 | US FAERS | |
| 47 | Drug exposure during pregnancy | FAERS: 5 | US FAERS | |
| 48 | Feeling Cold | FAERS: 5 | US FAERS | |
| 49 | Infusion site urticaria | FAERS: 5 | US FAERS | |
| 50 | Myalgia | FAERS: 5 | US FAERS | |
| 51 | Unevaluable event | FAERS: 5 | US FAERS | |
| 52 | Wrong technique in drug usage process | FAERS: 5 | US FAERS | |
| 53 | Anaphylactic shock | FAERS: 4 | US FAERS | |
| 54 | Blood glucose increased | FAERS: 4 | US FAERS | |
| 55 | Infusion site rash | FAERS: 4 | US FAERS | |
| 56 | Injection site erythema | FAERS: 4 | US FAERS | |
| 57 | Medication Error | FAERS: 4 | US FAERS | |
| 58 | Palpitations | FAERS: 4 | US FAERS | |
| 59 | Retching | FAERS: 4 | US FAERS | |
| 60 | Anxiety | FAERS: 3 | US FAERS | |
| 61 | Arthritis | FAERS: 3 | US FAERS | |
| 62 | Blood pressure immeasurable | FAERS: 3 | US FAERS | |
| 63 | Discomfort | FAERS: 3 | US FAERS | |
| 64 | Hypoventilation | FAERS: 3 | US FAERS | |
| 65 | Hypoxia | FAERS: 3 | US FAERS | |
| 66 | Injection Site Reaction | FAERS: 3 | US FAERS | |
| 67 | Musculoskeletal Pain | FAERS: 3 | US FAERS | |
| 68 | Respiratory arrest | FAERS: 3 | US FAERS | |
| 69 | Sinus Tachycardia | FAERS: 3 | US FAERS | |
| 70 | Somnolence | FAERS: 3 | US FAERS | |
| 71 | Thrombosis in device | FAERS: 3 | US FAERS | |
| 72 | Wheezing | FAERS: 3 | US FAERS | |
| 73 | Angioedema | FAERS: 2 | US FAERS | |
| 74 | Aphasia | FAERS: 2 | US FAERS | |
| 75 | Asthma | FAERS: 2 | US FAERS | |
| 76 | Blood iron decreased | FAERS: 2 | US FAERS | |
| 77 | Blood potassium increased | FAERS: 2 | US FAERS | |
| 78 | Bone pain | FAERS: 2 | US FAERS | |
| 79 | Complications of maternal exposure to therapeutic drugs | FAERS: 2 | US FAERS | |
| 80 | Deafness | FAERS: 2 | US FAERS | |
| 81 | Drug dispensing error | FAERS: 2 | US FAERS | |
| 82 | Drug ineffective | FAERS: 2 | US FAERS | |
| 83 | Dysarthria | FAERS: 2 | US FAERS | |
| 84 | Epistaxis | FAERS: 2 | US FAERS | |
| 85 | Extremity contracture | FAERS: 2 | US FAERS | |
| 86 | Flank Pain | FAERS: 2 | US FAERS | |
| 87 | Flatulence | FAERS: 2 | US FAERS | |
| 88 | Hyperpyrexia | FAERS: 2 | US FAERS | |
| 89 | Hyperventilation | FAERS: 2 | US FAERS | |
| 90 | Incontinence | FAERS: 2 | US FAERS | |
| 91 | Incorrect drug administration duration | FAERS: 2 | US FAERS | |
| 92 | Infusion site pain | FAERS: 2 | US FAERS | |
| 93 | Injection site irritation | FAERS: 2 | US FAERS | |
| 94 | Injection site pruritus | FAERS: 2 | US FAERS | |
| 95 | Livedo Reticularis | FAERS: 2 | US FAERS | |
| 96 | Mental status changes | FAERS: 2 | US FAERS | |
| 97 | Musculoskeletal chest pain | FAERS: 2 | US FAERS | |
| 98 | Neck Pain | FAERS: 2 | US FAERS | |
| 99 | Neuralgia | FAERS: 2 | US FAERS | |
| 100 | Oropharyngeal swelling | FAERS: 2 | US FAERS | |
| 101 | Presyncope | FAERS: 2 | US FAERS | |
| 102 | Restlessness | FAERS: 2 | US FAERS | |
| 103 | Shock | FAERS: 2 | US FAERS | |
| 104 | Tremor | FAERS: 2 | US FAERS | |
| 105 | Vasospasm | FAERS: 2 | US FAERS | |
| 106 | Vertigo | FAERS: 2 | US FAERS | |
| 107 | Abasia | FAERS: 1 | US FAERS | |
| 108 | Acidosis | FAERS: 1 | US FAERS | |
| 109 | Administration related reaction | FAERS: 1 | US FAERS | |
| 110 | Adverse event | FAERS: 1 | US FAERS | |
| 111 | Agitation | FAERS: 1 | US FAERS | |
| 112 | Alanine Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 113 | Amnesia | FAERS: 1 | US FAERS | |
| 114 | Application site erythema | FAERS: 1 | US FAERS | |
| 115 | Application site induration | FAERS: 1 | US FAERS | |
| 116 | Application site nodule | FAERS: 1 | US FAERS | |
| 117 | Application site pain | FAERS: 1 | US FAERS | |
| 118 | Application site swelling | FAERS: 1 | US FAERS | |
| 119 | Application site warmth | FAERS: 1 | US FAERS | |
| 120 | Arthropathy | FAERS: 1 | US FAERS | |
| 121 | Aspartate Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 122 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 123 | Autonomic nervous system imbalance | FAERS: 1 | US FAERS | |
| 124 | Blindness | FAERS: 1 | US FAERS | |
| 125 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 126 | Cardiac discomfort | FAERS: 1 | US FAERS | |
| 127 | Cardiovascular insufficiency | FAERS: 1 | US FAERS | |
| 128 | Catheter related complication | FAERS: 1 | US FAERS | |
| 129 | Cellulitis | FAERS: 1 | US FAERS | |
| 130 | Choking sensation | FAERS: 1 | US FAERS | |
| 131 | Chromaturia | FAERS: 1 | US FAERS | |
| 132 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 133 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 134 | Diaphragmalgia | FAERS: 1 | US FAERS | |
| 135 | Documented hypersensitivity to administered product | FAERS: 1 | US FAERS | |
| 136 | Drooling | FAERS: 1 | US FAERS | |
| 137 | Drug administration error | FAERS: 1 | US FAERS | |
| 138 | Dry skin | FAERS: 1 | US FAERS | |
| 139 | Dyspepsia | FAERS: 1 | US FAERS | |
| 140 | Ecchymosis | FAERS: 1 | US FAERS | |
| 141 | Electrocardiogram abnormal | FAERS: 1 | US FAERS | |
| 142 | Epilepsy | FAERS: 1 | US FAERS | |
| 143 | Expired product administered | FAERS: 1 | US FAERS | |
| 144 | Facial Pain | FAERS: 1 | US FAERS | |
| 145 | Facial Paresis | FAERS: 1 | US FAERS | |
| 146 | Gamma-Glutamyltransferase Increased | FAERS: 1 | US FAERS | |
| 147 | HELLP Syndrome | FAERS: 1 | US FAERS | |
| 148 | Hepatotoxicity | FAERS: 1 | US FAERS | |
| 149 | Hunger | FAERS: 1 | US FAERS | |
| 150 | Inappropriate schedule of drug administration | FAERS: 1 | US FAERS | |
| 151 | Incoherent | FAERS: 1 | US FAERS | |
| 152 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 153 | Incorrect drug administration rate | FAERS: 1 | US FAERS | |
| 154 | Incorrect route of drug administration | FAERS: 1 | US FAERS | |
| 155 | Induration | FAERS: 1 | US FAERS | |
| 156 | Inflammation | FAERS: 1 | US FAERS | |
| 157 | Influenza | FAERS: 1 | US FAERS | |
| 158 | Infusion site erythema | FAERS: 1 | US FAERS | |
| 159 | Infusion site nerve damage | FAERS: 1 | US FAERS | |
| 160 | Infusion site swelling | FAERS: 1 | US FAERS | |
| 161 | Injection site discomfort | FAERS: 1 | US FAERS | |
| 162 | Injection site extravasation | FAERS: 1 | US FAERS | |
| 163 | Injection site infection | FAERS: 1 | US FAERS | |
| 164 | Injection site inflammation | FAERS: 1 | US FAERS | |
| 165 | Injection site phlebitis | FAERS: 1 | US FAERS | |
| 166 | Injection site streaking | FAERS: 1 | US FAERS | |
| 167 | Injection site thrombosis | FAERS: 1 | US FAERS | |
| 168 | Injection site warmth | FAERS: 1 | US FAERS | |
| 169 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 170 | Joint Range of Motion Decreased | FAERS: 1 | US FAERS | |
| 171 | Laryngospasm | FAERS: 1 | US FAERS | |
| 172 | Limb discomfort | FAERS: 1 | US FAERS | |
| 173 | Malabsorption | FAERS: 1 | US FAERS | |
| 174 | Medication monitoring error | FAERS: 1 | US FAERS | |
| 175 | Memory impairment | FAERS: 1 | US FAERS | |
| 176 | Metabolic acidosis | FAERS: 1 | US FAERS | |
| 177 | Moaning | FAERS: 1 | US FAERS | |
| 178 | Musculoskeletal discomfort | FAERS: 1 | US FAERS | |
| 179 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 180 | Myoclonus | FAERS: 1 | US FAERS | |
| 181 | Necrosis | FAERS: 1 | US FAERS | |
| 182 | Oropharyngeal discomfort | FAERS: 1 | US FAERS | |
| 183 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 184 | Overdose | FAERS: 1 | US FAERS | |
| 185 | Pancytopenia | FAERS: 1 | US FAERS | |
| 186 | Physical disability | FAERS: 1 | US FAERS | |
| 187 | Pleuritic pain | FAERS: 1 | US FAERS | |
| 188 | Pneumothorax | FAERS: 1 | US FAERS | |
| 189 | Polyarthritis | FAERS: 1 | US FAERS | |
| 190 | Prescribed overdose | FAERS: 1 | US FAERS | |
| 191 | Product lot number issue | FAERS: 1 | US FAERS | |
| 192 | Product substitution issue | FAERS: 1 | US FAERS | |
| 193 | Product use issue | FAERS: 1 | US FAERS | |
| 194 | Pulmonary Embolism | FAERS: 1 | US FAERS | |
| 195 | Rash erythematous | FAERS: 1 | US FAERS | |
| 196 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 197 | Shoulder Pain | FAERS: 1 | US FAERS | |
| 198 | Similar reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 199 | Skin necrosis | FAERS: 1 | US FAERS | |
| 200 | Skin tightness | FAERS: 1 | US FAERS | |
| 201 | Skin weeping | FAERS: 1 | US FAERS | |
| 202 | Stevens-Johnson Syndrome | FAERS: 1 | US FAERS | |
| 203 | Stress | FAERS: 1 | US FAERS | |
| 204 | Sudden Visual Loss | FAERS: 1 | US FAERS | |
| 205 | Therapy cessation | FAERS: 1 | US FAERS | |
| 206 | Thrombophlebitis | FAERS: 1 | US FAERS | |
| 207 | Thrombosis | FAERS: 1 | US FAERS | |
| 208 | Tinnitus | FAERS: 1 | US FAERS | |
| 209 | Tonic clonic movements | FAERS: 1 | US FAERS | |
| 210 | Toxic Epidermal Necrolysis | FAERS: 1 | US FAERS | |
| 211 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 212 | Transcription medication error | FAERS: 1 | US FAERS | |
| 213 | Uterine spasm | FAERS: 1 | US FAERS | |
| 214 | Visual Impairment | FAERS: 1 | US FAERS | |
| 215 | Wound dehiscence | FAERS: 1 | US FAERS | |
| 216 | Wrong technique in product usage process | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.